Literature DB >> 7787544

Diagnosis and management of Clostridium difficile infection.

S Tabaqchali1, P Jumaa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7787544      PMCID： PMC2549751          DOI： 10.1136/bmj.310.6991.1375

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  28 in total

1.  Outbreak of clindamycin-associated colitis.

Authors:  S A Kabins; T J Spira
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  Clostridium difficile: isolation and characteristics.

Authors:  S Hafiz; C L Oakley
Journal:  J Med Microbiol       Date:  1976-05       Impact factor: 2.472

3.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

4.  Staphylococcal enterocolitis--treatment with oral vancomycin.

Authors:  M Y Khan; W H Hall
Journal:  Ann Intern Med       Date:  1966-07       Impact factor: 25.391

5.  Undescribed toxin in pseudomembranous colitis.

Authors:  H E Larson; J V Parry; A B Price; D R Davies; J Dolby; D A Tyrrell
Journal:  Br Med J       Date:  1977-05-14

6.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

7.  Aetiology of antimicrobial-agent-associated colitis.

Authors:  W L George; V L Sutter; E J Goldstein; S L Ludwig; S M Finegold
Journal:  Lancet       Date:  1978-04-15       Impact factor: 79.321

8.  Management and control of a large outbreak of diarrhoea due to Clostridium difficile.

Authors:  T D Cartmill; H Panigrahi; M A Worsley; D C McCann; C N Nice; E Keith
Journal:  J Hosp Infect       Date:  1994-05       Impact factor: 3.926

9.  Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment.

Authors:  R Fekety; K H Kim; D Brown; D H Batts; M Cudmore; J Silva
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321
View more
  7 in total

1.  Nosocomial empyema caused by Clostridium difficile.

Authors:  A J Simpson; S S Das; S Tabaqchali
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

2.  Clostridium difficile infection of the gut.

Authors:  A P Dodson; S P Borriello
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

3.  Usefulness of culture in the diagnosis of Clostridium difficile infection.

Authors:  T V Riley; R A Bowman; C L Golledge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

4.  Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  J Jacobs; B Rudensky; J Dresner; A Berman; M Sonnenblick; Y van Dijk; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

Review 5.  Drug-induced diarrhoea.

Authors:  O Chassany; A Michaux; J F Bergmann
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

6.  Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins.

Authors:  E Rothschild; A Rauss; G Danan
Journal:  BMJ       Date:  1996-03-23

7.  Brewer's yeast and Saccharomyces boulardii both attenuate Clostridium difficile-induced colonic secretion in the rat.

Authors:  F Izadnia; C T Wong; S A Kocoshis
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.